Feedback Opportunity: Survey on the FDA/CORE Outbreak Investigation Table (CIT)

Outbreak Investigations & Safety Advisories Center for Food Safety and Applied Nutrition  Survey on the FDA/CORE Outbreak Investigation Table (CIT) Greetings, FDA's Coordinated Outbreak Response and Evaluation (CORE) would like your feedback on its newly released CORE Outbreak Investigation Table (CIT). The CIT, located about halfway down the webpage, is a list of outbreak investigations being managed by FDA's CORE Response Teams. The CIT was developed to publicly share current outbreaks earlier on in the investigation process, even if there isn't actionable advice for the public yet.   Your feedback is completely voluntary, and your responses will be kept secure to the extent allowed by law. You received this survey invitation because you have previously shown interest in foodborne outbreaks and may be using the CIT. Your feedback is crucial for helping us determine what improvements could be made to ensure that the table is informative, easy to understand, and an effective tool for the public. Please click the link below to take the 10-minute survey about the CIT. Your survey response is requested by May 11, 2022. Take the survey Clicking on the link to the survey and taking the survey implies consent to participate. You may quit the survey at any time without submitting. If you have any questions about this survey, please contact Lindsay.Walerstein@fda.hhs.gov. Thank you for considering this request, and for your time. If you do not wish to participate in future survey testing, please email Lindsay.Walerstein@fda.hhs.gov. Paperwork Reduction Act Statement  Paperwork Reduction Act Statement: Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspects of this collection of information, including suggestions for reducing burden to PRAStaff@fda.hhs.gov. Recalls, Outbreaks & Emergencies Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA